Rockwell Medical, Inc.
RMTI
$7.96
-$0.11-1.30%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 69.39M | 67.68M | 69.26M | 75.58M | 87.97M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 69.39M | 67.68M | 69.26M | 75.58M | 87.97M |
| Cost of Revenue | 57.10M | 56.13M | 57.56M | 64.13M | 72.55M |
| Gross Profit | 12.29M | 11.55M | 11.70M | 11.45M | 15.42M |
| SG&A Expenses | 16.77M | 16.36M | 16.39M | 16.26M | 16.71M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 73.91M | 72.49M | 73.95M | 80.39M | 89.26M |
| Operating Income | -4.52M | -4.81M | -4.69M | -4.81M | -1.29M |
| Income Before Tax | -5.08M | -5.40M | -5.31M | -5.52M | -2.10M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -5.08 | -5.40 | -5.31 | -5.52 | -2.10 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -5.08M | -5.40M | -5.31M | -5.52M | -2.10M |
| EBIT | -4.52M | -4.81M | -4.69M | -4.81M | -1.29M |
| EBITDA | -2.43M | -2.65M | -2.50M | -2.62M | 896.00K |
| EPS Basic | -1.37 | -1.51 | -1.55 | -1.72 | -0.78 |
| Normalized Basic EPS | -0.90 | -0.97 | -0.99 | -1.03 | -0.39 |
| EPS Diluted | -1.39 | -1.54 | -1.57 | -1.76 | -0.86 |
| Normalized Diluted EPS | -0.90 | -0.97 | -0.99 | -1.03 | -0.40 |
| Average Basic Shares Outstanding | 15.44M | 14.92M | 14.38M | 13.73M | 13.28M |
| Average Diluted Shares Outstanding | 15.44M | 14.92M | 14.38M | 13.73M | 13.37M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |